【中泰医药】脑机动态定期更新 近期部分重要进展： 1、赵继宗院士牵头制定的《植入式脑机接口临床应用路径管理中国专家共识（2026 版）》正式发布，推动 iBCI 临床转化科学、安全、有序发展； 2、民政部印发《关于进一步推进民政科技创新的指导意见》，《意见》要求广泛应用人形机器人、脑机接口、人 工智能等前沿技术，开展失能失智预防和抗衰老、生活照料和康复护理、精神慰藉和社会参与促进、安全风险监 测和紧急救援、老年宜居 仅需3分钟就能迅速打开血脑屏障，与血脑屏障未开放的脑组织相比，药物浓度可以平均提高8倍，并且在治疗后6 小时关闭血脑屏障，疗效和安全性均优于国际相关报道； 7、Ybrain招募三星电子和VUNO前高管，推广基于tDCS和脑电图技术的非口服抗抑郁药、打造AI心理健康生态系 统； 8、韩国数字医疗企业Neofect宣布与韩德联合财团合作，共同推进脑机接口商业化，项目将耗时36个月（2025.9- 2028.8）研发基于脑神经控制的脑卒中患者上肢辅助与康复机器人系统。 【中泰医药】脑机动态定期更新 近期部分重要进展： 1、赵继宗院士牵头制定的《植入式脑机接口临床应用路径管理中国专家共识（2026 版）》 ...

1. Report Industry Investment Rating There is no information about the industry investment rating in the report. 2. Core Views of the Report - The prices of various commodities in the chemical and agricultural sectors showed different trends on February 4, 2026, compared to the previous day [4]. - The macro - economic news includes rumors of VAT rate hikes in some industries, major corporate mergers and IPO plans, and policy directions in different fields [6][7]. - For different commodity futures, the market conditions are affected by supply - demand relationships, seasonal factors, and macro - economic factors, and corresponding trading strategies are proposed [11][13][15]. - In the stock market, A - shares showed a general upward trend on February 3, while欧美 stocks declined. Different sectors had different performances, and trading strategies are suggested for different investors [22][23]. 3. Summary by Relevant Catalogs 3.1 Chemical Industry - On February 4, 2026, most chemical futures showed price increases, such as natural rubber with a 0.803% increase, 20 - number rubber with a 0.955% increase, and asphalt with a 0.997% increase. Only PVC and caustic soda showed price decreases, with PVC down 0.335% and caustic soda down 0.863% [4]. 3.2 Macro - Economic News - Rumors of VAT rate hikes in the financial and Internet value - added service industries, especially in the game industry from 6% to 32%, turned out to be false [6]. - SpaceX merged with xAI, with the combined company valued at $1.25 trillion, and an expected IPO later this year [6]. - 30 provinces in China have set their GDP growth targets for 2026, with many economic powerhouses aiming for over 5% growth [6]. - Multiple commercial aerospace companies are in the process of going public, and they may list on the stock market intensively in the next one or two years [7]. - The Ministry of Industry and Information Technology emphasizes technological breakthroughs in future industries such as 6G, quantum technology, etc. [7]. - The Hong Kong Monetary Authority announced a financial technology promotion blueprint and will launch four flagship projects [7]. - There were disputes about OpenAI's attitude towards Nvidia's AI chips, but Nvidia's investment plan in OpenAI is still progressing [7]. - Different Fed officials have different views on interest - rate cuts. Waymo completed a new round of $16 billion in financing, with a post - investment valuation of $126 billion [8]. 3.3 Main Commodity Morning Meeting Views 3.3.1 Agricultural Products - **Sugar**: The supply - demand situation is loose both at home and abroad. The domestic sugar price is expected to remain in a weak and volatile state. It is advisable to be cautious when short - selling and focus on short - selling opportunities after a rebound [11]. - **Corn**: The market faces seasonal selling pressure before the Spring Festival and weakening demand. The price is in a high - level volatile state. It is recommended to wait and see, with the upper pressure at 2275 yuan and the lower support at 2250 yuan [11]. - **Peanut**: The price is expected to continue to fluctuate at the bottom in the short term. The lower support levels are 8000 yuan and 7900 yuan, and the upper pressure is 8100 yuan [11]. - **Pig**: The supply of pigs is temporarily tightened before the Spring Festival, and the futures market is expected to remain volatile [11][13]. - **Egg**: The spot market is stable, and the futures market shows a pattern of near - term strength and long - term weakness, seeking downward support [13]. - **Jujube**: The price is expected to remain stable in the short term. The downstream demand is fragmented, and the futures market is seeking downward support [13]. - **Cotton**: The supply has a long - term bullish factor of expected yield reduction, but the high inventory suppresses the upward space. The price is expected to remain in a high - level volatile state. It is advisable to operate cautiously on the long side, with the support range at 14500 - 14600 yuan [13]. 3.3.2 Energy and Chemicals - **Caustic Soda**: The fundamentals are in an oversupply situation, and attention should be paid to the impact of supply - side changes on prices [13]. - **Coking Coal and Coke**: The prices of coking coal in the production areas have declined, and the replenishment of steel and coking enterprises is coming to an end. The prices are expected to fluctuate and run [13]. - **Log**: The price is expected to maintain a relatively strong and volatile state, but the upward space is limited. It is advisable to adopt a volatile trading strategy, with the upper pressure at 805 yuan and the lower support at 795 yuan [13][15]. - **Pulp**: The supply - demand situation is weak. The price is expected to be under pressure and run weakly in the short term. It is recommended to wait and see or try short - selling lightly when the price is high, with the upper pressure at 5300 yuan/ton and the lower support at 5250 yuan/ton [15]. - **Offset Printing Paper**: The supply - demand relationship is in a weak balance. It is recommended to wait and see. If the price effectively breaks below 4030 yuan, the downward space may be opened [16]. 3.3.3 Non - ferrous Metals - **Copper and Aluminum**: The copper price is under pressure due to market uncertainties and the rising US dollar index. The aluminum supply is increasing, the demand is showing signs of stabilization, and the inventory accumulation speed has slowed down, but the structural contradiction remains. The market sentiment has stabilized, and attention should be paid to macro - risks [18]. - **Alumina**: The fundamentals are in an oversupply situation, waiting for new market drivers [20]. - **Rebar and Hot - Rolled Coil**: The demand is weakening as the holiday approaches, and the steel prices are expected to be under slight pressure and run weakly [20]. - **Silicon Ferrosilicon and Manganese Silicon**: The overall fundamentals are relatively healthy, but the market lacks expected drivers. The prices are expected to run weakly with a narrowing range, and the cost provides certain support. It is advisable to have a callback - and - long - biased trading idea and pay attention to the macro - atmosphere [20]. - **Lithium Carbonate**: The price rebounded strongly after a sharp decline, showing strong support below. It is expected to maintain a high - level volatile state in the short term. It is recommended to wait and see, with the upper pressure at 151880 yuan and the lower support at 137520 yuan [20][22]. 3.3.4 Options and Finance - **Stock Index Options**: On February 3, A - shares showed a general upward trend, and different stock index futures and options had different performance indicators. Trend investors can focus on the strength - weakness arbitrage opportunities between varieties, and volatility investors can hold short - wide - straddle positions to short - sell volatility. The stock market is likely to fluctuate in the two weeks before the Spring Festival, and attention should be paid to structural opportunities [22]. - **Stock Market**: A - shares closed higher on February 3, with active performance in some concept sectors. The欧美 stock market declined, and technology stocks were under pressure. The trading strategy is to participate in the rebound lightly when the price stabilizes after a sharp decline, not to chase the rise, and to realize profits when the price rises [22][23].

地址：北京市朝阳区朝阳门外大街甲 6 号万通中心 D 座 20 层（100020） 总机：010-8535 6666 注:本报告资讯信息来源于万得资讯和金十数据，冠通研究整理编辑 本公司具备期货交易咨询业务资格，请务必阅读免责声明。 分析师：王静，执业资格证号 F0235424/Z0000771。 免责声明： 本报告中的信息均来源于公开资料，我公司对这些信息的准确性和完整性不作任何保证。报告中的内容和 意见仅供参考，并不构成对所述品种买卖的出价或征价。我公司及其雇员对使用本报告及其内容所引发的 任何直接或间接损失概不负责。本报告仅向特定客户传送，版权归冠通期货所有。未经我公司书面许可， 任何机构和个人均不得以任何形式翻版，复制，引用或转载。如引用、转载、刊发，须注明出处为冠通期 货股份有限公司。 资讯早间报 发布日期：2026/2/4 隔夜夜盘市场走势 1. 国内商品期市日盘多数收跌，贵金属走势分化，沪银跌 16.71%，钯涨 8.62%； 基本金属跌幅居前，沪锡跌 6.7%；能源品全部下跌，原油跌 4.93%。贵金属、基 本金属夜盘反弹，沪银涨 5.93%，沪金涨 4.2%，沪锡涨 6.64%。 2.国际贵 ...

1、美国预计将启动一项 120 亿美元矿产储备计划，范围预计涵盖稀土、铜和锂等关键矿产； 2、SpaceX 收购 xAI，预计估值将达 1.25 万亿美元；浙大发布全球首个峰值速度达到 10m/s 的全尺寸 人形机器人； 3、2026 年中央一号文件：促进人工智能与农业发展相结合；上海：大力培育发展脑机接口、第四代半 导体等未来产业； 文字早评 2026/02/04 星期三 宏观金融类 股指 【行情资讯】 4、黄金/白银现货最高反弹 6.24%/11%；日经 225 指数涨近 4%，创历史新高；韩国综合指数涨近 7%。 基差年化比率： IF 当月/下月/当季/隔季：1.63%/1.37%/3.96%/4.07%； IC 当月/下月/当季/隔季：-3.32%/0.51%/6.16%/5.23%； IM 当月/下月/当季/隔季：-1.44%/2.85%/11.41%/8.91%； IH 当月/下月/当季/隔季：1.77%/0.47%/1.63%/2.59%。 【策略观点】 近期政策更多是担心市场短期过热，慢牛才是政策的长期导向。中长期看政策支持资本市场的态度未变， 短期关注市场的节奏，策略上以逢低做多的思路为主。 ...

Company and Industry Insights - Texas Instruments is reportedly in deep negotiations to acquire chip design company Synaptics for approximately $7 billion, with Synaptics' stock surging over 45% post-announcement [7] - CATL and Fulin Precision are increasing capital in their subsidiary Jiangxi Shenghua to establish a new 500,000-ton ferrous oxalate project, securing upstream raw material supply [7] - Good Products' controlling shareholder, Ningbo Hanyi, has received an execution notice due to overdue debts, potentially putting some of its shares at risk of forced execution [7] - Tianyi Research Institute has completed IPO counseling registration with the Hunan Securities Regulatory Bureau, known for launching 37 satellites into space, dubbed the "Pinduoduo" of the aerospace industry [8] - Huafa Co. plans to raise no more than 3 billion yuan through a private placement to fund nine real estate projects, supplementing project development capital [8] - Kailong High-Tech intends to acquire 70% of Jinhua Wanda through a combination of stock issuance and cash payment, with shares resuming trading on February 4 [8] - Cambrian Technology experienced a drop of over 14% during trading, closing down 9.18% at 1,128 yuan per share, nearing a 30% decline from its high in August [8] - Walmart's market capitalization has surpassed $1 trillion for the first time, with a year-to-date increase of 13%, joining the exclusive club of trillion-dollar retail companies [8] - Disney has appointed Josh D'Amaro as the new CEO, succeeding Bob Iger, with a base salary of $2.5 million and a target one-time stock award of $9.7 million [8] - HP has appointed Bruce Broussard as interim CEO, effective immediately, following the resignation of Enrique Lores [8] - Sun Kai, Vice President and Secretary of the Board at Industrial Bank, has increased his stake in the company by purchasing 40,000 shares, reflecting confidence in the company's future development [8]

交易咨询资格号： 证监许可[2012]112 晨会纪要 2026 年 2 月 4 日 联系人：王竣冬 期货从业资格：F3024685 交易咨询从业证书号：Z0013759 研究咨询电话： 0531-81678626 客服电话： 400-618-6767 公司网址： www.ztqh.com 请务必阅读正文之后的免责声明部分 [Table_QuotePic] 中泰微投研小程序 | 4 / 7 / 7 / 4 | | 卒」卒4日听刊 | | | | --- | --- | --- | --- | --- | | 趋势空头 | 農荡偏空 | 農药 | 農荡偏多 | 趋势多头 | | | に | 橡胶 | 中证1000指数期货 | | | | 红枣 | 自糖 | 燃油 | | | | 铁矿石 | 多晶硅 | 三十债 | | | | 甲醇 | 棉纱 | 十债 | | | | РУС | 尿素 | 上证50股指期货 | | | | 塑料 | 棉花 | 二债 | | | | 生猪 | 胶版印刷纸 | 沪深300股指期货 | | | | 原油 | 玉米 | 五债 | | | | 液化石油气 | 乙二醇 | 沥青 | | | ...

Policy Developments - Shanghai aims to vigorously cultivate and develop future industries such as brain-computer interfaces and fourth-generation semiconductors, as stated in the government work report presented at the Shanghai Municipal People's Congress [1] Drug and Medical Device Approvals - Novartis announced that its innovative biological drug Cosentyx (secukinumab) has received approval from the National Medical Products Administration in China for a new indication to treat active non-radiographic axial spondyloarthritis in adults who have had an inadequate response to non-steroidal anti-inflammatory drugs [2] - Hualan Biological announced that its recombinant Exendin-4-Fc fusion protein injection (HL08) has received clinical trial approval for use in adult patients with obesity or overweight, expanding its indications beyond type 2 diabetes [3] - Bibet's BEBT-701, a globally first AGT/PCSK9 dual-target siRNA drug, has received approval for clinical trials to treat mild to moderate hypertension combined with elevated low-density lipoprotein cholesterol [4] - Zhifei Biological's mRNA vaccine for shingles has received clinical trial approval from the National Medical Products Administration [5] Financial Data - Yaokang Biological reported a total revenue of 793 million yuan for 2025, a year-on-year increase of 15.49%, and a net profit of 144 million yuan, reflecting a growth of 31.49% [6] Industry Developments - Jichuan Pharmaceutical's wholly-owned subsidiary has signed an exclusive commercialization rights agreement for the Inusimab injection, paying an authorization fee of 80 million yuan [7][8] - Insilico Medicine announced it received a milestone payment of 39 million HKD from Menarini after the MEN2501 project completed its first patient dosing in Phase I clinical trials [9] - WuXi Biologics has signed a licensing and research service agreement with Vertex Pharmaceuticals for an innovative trispecific T cell engager, which will be used to treat B cell-mediated autoimmune diseases [10]

Core Viewpoint - BGI Genomics plans to enhance its technology matrix through the acquisition of assets, aiming to solidify its position as a leading manufacturer in the life sciences sector by integrating cutting-edge technologies [1][4]. Group 1: Acquisition Details - BGI Genomics intends to acquire 100% equity of Sanjian Qifa and BGI Xifeng for a total cash consideration of 366 million yuan, which will incorporate two core technologies: spatial genomics and nanopore sequencing [2]. - The acquisition will enable BGI Genomics to establish a comprehensive technology ecosystem covering short-read, long-read, and spatial genomics, facilitating a one-stop service from library construction to sequencing and data analysis [2]. - The counterparties of the transaction have provided clear performance commitments, with Sanjian Qifa promising a cumulative net profit of no less than 50.1 million yuan from 2026 to 2028, and BGI Xifeng committing to a cumulative net profit of no less than 82.8 million yuan from 2028 to 2030 [2]. Group 2: Strategic Significance - The acquisition is expected to significantly reduce related-party transactions and resolve potential competition issues in the nanopore sequencing business, thereby enhancing the company's sustainable operational capabilities [2]. - Post-acquisition, BGI Genomics will achieve resource sharing and synergy in supply chain procurement, technology development, and customer service, which will serve as important growth engines for the company [2]. Group 3: Market Position and Performance - BGI Genomics has shown a notable improvement in its operational fundamentals, with a projected net loss of 221 million to 273 million yuan for 2025, representing a reduction in losses by approximately 60% compared to the previous year [3]. - The company secured 61% of the domestic high-throughput sequencing instrument market in 2025, with 232 units won in bids, demonstrating strong market penetration and customer recognition [3]. - BGI Genomics has been proactive in the AI pathology field since 2019, establishing the Spatial Pathology Alliance in 2025 and successfully registering its self-developed PMIF-20 pathology slide staining scanner, reinforcing its foundation for integrating AI with pathology analysis [3].

Company News - Guizhou Moutai repurchased 329,800 shares in January, accounting for 0.0263% of the total share capital, with a total payment of 451 million yuan. By the end of January, the total repurchased shares reached 416,900, accounting for 0.0333% of the total share capital, with a total payment of 571 million yuan (excluding transaction fees) [3] - Contemporary Amperex Technology Co., Ltd. repurchased 15,990,800 A-shares by January 31, accounting for 0.3628% of the total A-shares, with a maximum transaction price of 317.63 yuan/share and a minimum of 231.50 yuan/share, totaling 4.386 billion yuan (excluding transaction fees) [3] - Zhiyang Innovation announced plans to acquire control of Lingming Photon through stock issuance, convertible bonds, and cash payments, which is expected to constitute a major asset restructuring. The stock will be suspended from trading starting February 4 for no more than five trading days [3] - Kailong High-Tech plans to acquire 70% of Shenzhen Jinwangda Electromechanical Co., Ltd. through stock issuance and cash payment, with the transaction price yet to be determined. This acquisition is expected to constitute a major asset restructuring, and the stock will resume trading on February 4 [4] - Han Jian Heshan intends to acquire 99.9978% of Liaoning Xingfu New Materials Co., Ltd. through stock issuance and cash payment, with the transaction price still to be finalized. This transaction is expected to constitute a major asset restructuring and will not result in a restructuring listing, with the stock resuming trading on February 4 [4] - ST Cube announced a stock suspension for self-examination due to abnormal price fluctuations, with the stock resuming trading on February 4. The stock price has increased by 188.06% over eight trading days, raising concerns about market sentiment and potential risks of rapid price declines [5] - Jiashitang announced a share transfer agreement with Beijing Tongrentang Group, resulting in a change of controlling shareholder to Tongrentang Group and the actual controller to the State-owned Assets Supervision and Administration Commission of Beijing Municipal Government. The stock will resume trading on February 4 [6] - Juguang Technology's stock price has deviated significantly, with a cumulative increase of over 30% in three consecutive trading days. Despite the recent improvement in the optical communication industry, the revenue from this sector only accounted for about 7% of the company's total revenue as of Q3 2025 [6] Industry News - The People's Bank of China conducted a liquidity injection of 800 billion yuan through reverse repos on February 3, with various monetary policy tools showing net injections of 700 billion yuan for medium-term lending facilities and 1.744 trillion yuan for mortgage supplementary loans in January [2] - The Ministry of Commerce announced plans to optimize the implementation of appliance recycling and subsidy policies in 2026, with sales of six categories of home appliances and four categories of digital and smart products exceeding 15 million units and sales revenue nearing 59 billion yuan in January [2] - The Ministry of Industry and Information Technology emphasized the need to promote the construction of future industry pilot zones and enhance technological supply in key areas such as 6G, quantum technology, and hydrogen energy [2] - CITIC Securities reported that the introduction of capacity electricity pricing policies will be crucial for the independent development of energy storage, while the nuclear power market may face price impacts due to the release of lower limits on thermal power prices [7]

Core Insights - The establishment of the brain-computer interface (BCI) outpatient clinic at Wuxi People's Hospital offers new hope for patients suffering from neurological disorders, integrating multiple disciplines for comprehensive treatment [1][2] - The clinic utilizes both non-invasive and minimally invasive BCI technologies to provide diagnostic and therapeutic services for severe motor impairments, refractory neurological diseases, and mental health issues [2] Group 1: Clinic Operations - The BCI outpatient clinic officially opened on January 12, becoming the first platform in Wuxi to integrate BCI technology with multidisciplinary collaboration for precise diagnosis and treatment [1] - Patients can receive evaluations and treatment plans without the need to visit multiple departments, streamlining the healthcare process [1] Group 2: Patient Experiences - Patients have reported significant improvements in their conditions, such as the ability to walk independently after undergoing rehabilitation training guided by BCI technology [1] - The clinic's approach has provided families with renewed hope, as seen in the experiences shared by patients and their relatives [1] Group 3: Government Support and Future Plans - The Jiangsu provincial government has outlined plans to accelerate the promotion of new technologies and products by 2026, which includes the BCI technology [1] - The focus on "first sets" of equipment, new materials, and software indicates a supportive environment for innovative medical technologies [1] Group 4: Research and Development - The Wuxi Brain Science Innovation Demonstration Center is exploring various applications of BCI technology, including smart rehabilitation and human-machine interaction [2] - Collaborative efforts between strong brain technology and local government aim to develop diverse application scenarios for BCI technology in healthcare and industry [2]